U.S. stocks closed narrowly mixed amid firming oil prices, moderate housing data and some debate over Yellen's congressional testimony.» Read More
This year’s flu season is shaping up to be as bad as expected. That's good news for drug stores, but insurers and others could suffer.
Some of the names on the move ahead of the open.
U.S. stocks closed down in low volume trade on Tuesday, pressured by weakness abroad and a sharp decline in the utilities sector.
Stocks rose on Friday, after the S&P 500's best two-day streak in years.
NEW YORK, Dec 15- Healthcare companies including Aetna Inc, Mercer and Towers Watson& Co have invested hundreds of millions of dollars to build exchanges that allow company employees to buy their own insurance, betting that Corporate America wants to get out of managing workers' health benefits. By last year, blue chip names such as Sears Holding Corp and Walgreen...
NEW YORK, Dec 15- Healthcare companies including Aetna Inc, Mercer and Towers Watson Co have invested hundreds of millions of dollars to build exchanges that allow company employees to buy their own insurance, betting that Corporate America wants to get out of managing workers' health benefits. By last year, blue chip names like Sears Holding and Walgreen Co had...
Life expectancy is up, smoking is down, and obesity rates are on the rise again according to the new edition of America's Health Rankings.
U.S. stocks rallied into the close, with the Dow ending the day at a record amid encouraging economic reports on Wednesday.
Stocks rose on Tuesday, lifting the Dow and S&P 500 to their loftiest ever.
Actavis Plc, Gilead Sciences and other biotechs were among the biggest drivers, a day after Allergan agreed to be bought by Actavis. Shares of Actavis were up 8.7 percent at $269.60, helped by bullish analyst notes, while Gilead's stock rose 3.3 percent to $103.71 percent. "A little bit of a risk trade is coming back on, and those are the areas for the M&A," said Uri...
Actavis Plc, Gilead Sciences, Celgene and other biotech names were among the S&P 500' s biggest drivers, a day after Allergan agreed to be bought by Actavis. The S&P health care index was up 1.6 percent, while shares of Actavis were up 8.3 percent, Gilead's rose 3.3 percent and shares of Celgene were up 2.4 percent. Helping Actavis were bullish analyst notes.
Stocks fell Monday after data had Japan unexpectedly falling into a recession.
Starting Saturday, millions of Americans will begin to either re-enroll, or sign-up for the first time, for insurance plans at HealthCare.gov. Here's what investors need to know.
Obamacare's second open-enrollment season begins Saturday, with new deadlines, new technology and new projections of how many people will sign up.
Stocks stepped slightly higher Friday, with investors tracking the price of oil.
Stocks fell Wednesday as investors mulled the slowdown in Europe and earnings from retailers.
Stocks edged higher on Monday as investors tracked corporate results as the earnings season starts to wind down.
*Disney falls after results, Salix plummets. "Any kind of change in how the healthcare law is interpreted is going to affect healthcare stocks, probably insurers first," said Kim Forrest, senior equity research analyst at Fort Pitt Capital Group in Pittsburgh. Hospital operator Tenet Healthcare fell 6.5 percent to $47.85 while managed care facilities operator...
Stocks were little changed after data had creation of 214,000 jobs in October.
Members under the Medicaid health plans increased 28 percent to 2.3 million in the quarter ended Sept. 30, driven by additions in Florida, Kentucky and Georgia under the federal health insurance program for lower-income people, Wellcare said. Medicaid expansion has also helped other insurers such as UnitedHealth Group Inc, Centene Corp and Cigna Corp..